Molecular Modelling and Bioinformatics news

25 Jan 2012

Green light assigned to IRB Barcelona director Joan J. Guinovart in the “Traffic light” section of page 2 in the newspaper La Vanguardia. Further in the paper, a news page is devoted to the ERC Advanced Grants awarded to scientists working in Catalonia. Among them, IRB Barcelona researchers Cayetano González, Angel R. Nebreda and Modesto Orozco.

Link to La Vanguardia news (PDF in...

24 Jan 2012

Spanish newspaper ABC echoes IRB Barcelona success’ on the 2011 ERC Advanced Grant call launched by the main research institution of the European Union to support basic research.

Link to the ABC news piece (PDF in Spanish)

Link to ABC newspaper


<p>Modesto Orozco</p>
24 Jan 2012

The European Research Council (ERC) has awarded three ERC Advanced Grants to the Institute for Research in Biomedicine (IRB Barcelona), which account for 20% of the 15 grants awarded to centres in Spain, according to information provided by the European research organisation. Likewise, the ERC statistics for the 2011 call reveal that of the 2284 projects presented, 294 passed the screening process, which represents a success rate of 13%. Advanced Grants are the most competitive in Europe both in terms of funding and in terms of the reduced number of consolidated European researchers able to achieve one....

13 Dec 2011

The research, published in the journal Nature Genetics,
has addressed the genome of 100 patients with leukaemia and identified
that more than 1000 genes are mutated in the development of this

This study is a significant step forward to achievement of the
objectives set out by the Spanish Chronic Lymphocytic Leukaemia Genome

26 Oct 2011

Awarded by the European Research Council and providing funding of
around 2 and 3 million Euros over five years, ERC Advanced Grants are
given to a limited number of senior scientists.

The multidisciplinary project awarded within the category of
Physical Sciences and Engineering is specialized in chemistry and
computational biology, structural biology, biophysics, and
bioinformatics and will have direct applications in several fields of
biomedicine, such as the regulation of gene expression, and epigenetic

<p>Structure of NCBD when it is not bound to any other protein</p>
8 Sep 2011

Proteins, the molecular machines that carry out the majority of the functions within a cell, are typically seen as possessing a specific three-dimensional structure. Cellular processes (e.g. reproduction) are activated or deactivated by a molecular choreography that involves the binding of one protein to another. Of late, it has been recognized that even a small protein (say, of size 50 residues) can binding to multiple partners – this results in an advantageous situation for the cell wherein depending on the identity of the partner a different functional response can be generated. In parallel, it has become increasingly evident that a single static structure is a poor representation...

13 Jun 2011

In “L’Observatori”, broadcasted by Radio4, IRB Barcelona researcher Modesto Orozco explains his research efforts devoted to the development of new drugs that improve the people’s quality of life. The agreements drawn up by his laboratory with various I+D programmes from the private sector are good examples of these efforts.

8 Jun 2011

Several national media, such as La Vanguardia and RTVE, echoed the publication of the genome sequence of chronic lymphocytic leukemia in last Sunday’s advanced online version of Nature. The study, which involves Modesto Orozco and Josep L. Gelpí, both with the Joint Programme on Computational Biology between IRB Barcelona and the Barcelona Supercomputing Center (BSC), does not end here. Cells of 500 patients will be analyzed, with the hope of identifying alterations in cellular mechanisms that might serve as therapeutic targets in this disease.

6 Jun 2011

Using state-of-the-art technology, they seek to unraveled the genome of patients with chronic lymphocytic leukemia and give new key insights into the disease.

The study, which is a scientific milestone in this country, identifies four genes whose mutation causes this kind of leukemia.